Modelling the effect of GRP78 on anti-oestrogen sensitivity and resistance in breast cancer

Jignesh H. Parmar, Katherine L. Cook, Ayesha N. Shajahan-Haq, Pamela A.G. Clarke, Iman Tavassoly, Robert Clarke, John J. Tyson, William T. Baumann

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Understanding the origins of resistance to anti-oestrogen drugs is of critical importance to many breast cancer patients. Recent experiments show that knockdown of GRP78, a key gene in the unfolded protein response (UPR), can re-sensitize resistant cells to anti-oestrogens, and overexpression of GRP78 in sensitive cells can cause them to become resistant. These results appear to arise from the operation and interaction of three cellular systems: the UPR, autophagy and apoptosis. To determine whether our current mechanistic understanding of these systems is sufficient to explain the experimental results, we built a mathematical model of the three systems and their interactions. We show that the model is capable of reproducing previously published experimental results and some new data gathered specifically for this paper. The model provides us with a tool to better understand the interactions that bring about anti-oestrogen resistance and the effects of GRP78 on both sensitive and resistant breast cancer cells.

Original languageEnglish (US)
JournalInterface Focus
Issue number4
StatePublished - Aug 6 2013
Externally publishedYes


  • Anti-oestrogen resistance
  • Autophagy
  • Breast cancer
  • GRP78
  • Mathematical modelling
  • Unfolded protein response


Dive into the research topics of 'Modelling the effect of GRP78 on anti-oestrogen sensitivity and resistance in breast cancer'. Together they form a unique fingerprint.

Cite this